MarketInOut Stock Screener Log In | Sign Up

BrainsWay Ltd

TLV • Healthcare • Medical Devices • Quote as of 10/30/2026
BrainsWay Ltd stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeTLV
Market Capitalization1,391.95 mln
Float35.35 mln
Earnings Date11/11/2026

EPS

0.77
Stretched

P / E

44.91
High premium

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-1.1
Manipulation likely

Relative Strength

84 / 100
Strongly outperforming

Debt / Equity

0.09
Debt-free

Business Description

Founded in Jerusalem in 2003, BrainsWay is an Israeli medical technology company that helps patients with serious mental and neurological conditions without the need for surgery or medication. Its core product uses targeted magnetic pulses delivered through the skull to stimulate specific areas of the brain, and has received approval to treat conditions ranging from depression and OCD to smoking addiction and beyond. The company sells its technology to psychiatrists, hospitals, and clinics across the United States, East Asia, and other markets worldwide.

Key Fundamentals

EPS0.77
P/E44.91
ROE12.73
RPS5.01
ROIC13.68
ROA8.08
Interest Cover3.44
EBITDA, mln42.67
EV / EBITDA34.04
EV / EBIT38.83
Revenue, mln192
EV / Revenue7.57

Quote Details

Last 3,733.00
Change 77 (2.11%)
Open 3,656.00
Volume 45,080
Turnover 168,283,648
Average Volume 77,071

Financial Ratios

Pre-Tax Profit Margin16
Leverage Ratio1.54
Current Ratio3.59
Price / Book6.89
Price / Tangible Book6.89
Price / Cash Flow62.78
Price / Free Cash Flow107
Debt / Equity0.09
Price / Sales8.31

Financial Strength

Altman Z-Score8.07
Piotroski F-Score 6 / 9
Beneish M-Score-1.1
Price to Intrinsic Value5.61
Price to Graham Number4.05

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.95% 84 / 100   
1 Month -7.09% 27 / 100   
2 Months -19.46% 17 / 100   
6 Months -24.81% 19 / 100   
1 Year 41.67% 87 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog